Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
Covid was the making of this company but I wonder if it’s holding it back now in terms of a re-rate as the market can’t see the true value of the company. We now have a global diagnostics business with a track record of rapidly developing new tests yet the market seems transfixed on valuing based on Covid only and not the real long term potential for NCYT. Patience is key.
Given that a successful trial and / or emergency use approval will create significant demand for product then I am very sure that production “at risk” will have started. Production costs are negligible in comparison to the total R&D costs plus costs for getting the marketing authorisation / regulatory approval.
Saw this share tipped on Facebook this morning. By the time I’d done a quick bit of research, logged in and bought some shares it had gone up again. Hopefully I’ve caught this one at the start of a continued period of SP increases.
It’s my best share ever with so much gain in such a short time, I have done better out of this in the last few weeks than I have with anything else even long term holds.
The best thing is capacity and efficiency are about to increase and also don’t forget ARB is undervalued compared t it’s peers.
Don’t rely on Twitter. It’s here:
https://sec.report/otc/financial-report/268005
This was a small punt for me as one of 3 stocks I bought that had been tipped as potential 10-bagggers. This is one has multi bagged for me already in a very very short space of time bur has so much more to give. Don’t forget increased and more efficient mining capacity comes in stream in February as well.
Just seen it and saw the financial reports posted on the OTC site as well so knew this was coming. 40k tonight and OTC RNS in the morning - we all know where this is going.